The researchers discovered that small-molecule GLP-1 drugs significantly reduced how much dopamine, a neurotransmitter thats commonly associated with reward-motivated behaviors, was released, essentially changing the animals perception of how rewarding that food is. Gler hopes that his teams discovery can help guide future efforts in designing GLP-1 drugs that target specific parts of the brain, such as the reward center
Anti-Cancer Gene Expression Research with GHK-Cu One of the most surprising findings in GHK-Cu research involves its potential relevance to cancer biology
Retrieved 14 December 2017
[Read More] Svensson J, Lall S, Dickson SL, Bengtsson BA, Rmer J, Ahnfelt-Rnne I, Ohlsson C, Jansson JO
HONGDA's R&D centres keep an eye on these trends and put money into improving synthesis and making changes to next-generation peptides